Recent improvements and emerging issues in iPSC generation for the modeling of disease

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Recently, induced pluripotent stem cells (iPSCs) have attracted attention as a novel tool for the modeling of disease because of their potential to reveal new insights that have not been elucidated using animal models. Since iPSC generation was first reported, there have been many efforts to improve the method of generating iPSCs for clinical applications. To date, many methods for iPSC generation have been reported. Each has advantages and disadvantages for the modeling of disease, and thus the most appropriate method differs depending on the intended use of the iPSCs. Additionally, as the study of disease modeling with human iPSCs has progressed, the need to remove uncertainties due to variations in iPSCs cell lines has increasingly focused researchers’ attention on attaining experimental accuracy. Recognition of these uncertainties is important for the advancement of disease modeling studies with iPSCs.

Original languageEnglish
Title of host publicationHuman iPS Cells in Disease Modelling
PublisherSpringer Japan
Pages1-9
Number of pages9
ISBN (Electronic)9784431559665
ISBN (Print)9784431559641
DOIs
Publication statusPublished - 2016 Jan 1

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Uncertainty
Animals
Animal Models
Cells
Research Personnel
Cell Line

Keywords

  • Cell reprogramming
  • Disease modeling
  • Induced pluripotent stem cells

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Recent improvements and emerging issues in iPSC generation for the modeling of disease. / Seki, Tomohisa; Yuasa, Shinsuke; Fukuda, Keiichi.

Human iPS Cells in Disease Modelling. Springer Japan, 2016. p. 1-9.

Research output: Chapter in Book/Report/Conference proceedingChapter

Seki, Tomohisa ; Yuasa, Shinsuke ; Fukuda, Keiichi. / Recent improvements and emerging issues in iPSC generation for the modeling of disease. Human iPS Cells in Disease Modelling. Springer Japan, 2016. pp. 1-9
@inbook{db1e77f44c7c4bafae50ba03e8abae1d,
title = "Recent improvements and emerging issues in iPSC generation for the modeling of disease",
abstract = "Recently, induced pluripotent stem cells (iPSCs) have attracted attention as a novel tool for the modeling of disease because of their potential to reveal new insights that have not been elucidated using animal models. Since iPSC generation was first reported, there have been many efforts to improve the method of generating iPSCs for clinical applications. To date, many methods for iPSC generation have been reported. Each has advantages and disadvantages for the modeling of disease, and thus the most appropriate method differs depending on the intended use of the iPSCs. Additionally, as the study of disease modeling with human iPSCs has progressed, the need to remove uncertainties due to variations in iPSCs cell lines has increasingly focused researchers’ attention on attaining experimental accuracy. Recognition of these uncertainties is important for the advancement of disease modeling studies with iPSCs.",
keywords = "Cell reprogramming, Disease modeling, Induced pluripotent stem cells",
author = "Tomohisa Seki and Shinsuke Yuasa and Keiichi Fukuda",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-4-431-55966-5_1",
language = "English",
isbn = "9784431559641",
pages = "1--9",
booktitle = "Human iPS Cells in Disease Modelling",
publisher = "Springer Japan",

}

TY - CHAP

T1 - Recent improvements and emerging issues in iPSC generation for the modeling of disease

AU - Seki, Tomohisa

AU - Yuasa, Shinsuke

AU - Fukuda, Keiichi

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Recently, induced pluripotent stem cells (iPSCs) have attracted attention as a novel tool for the modeling of disease because of their potential to reveal new insights that have not been elucidated using animal models. Since iPSC generation was first reported, there have been many efforts to improve the method of generating iPSCs for clinical applications. To date, many methods for iPSC generation have been reported. Each has advantages and disadvantages for the modeling of disease, and thus the most appropriate method differs depending on the intended use of the iPSCs. Additionally, as the study of disease modeling with human iPSCs has progressed, the need to remove uncertainties due to variations in iPSCs cell lines has increasingly focused researchers’ attention on attaining experimental accuracy. Recognition of these uncertainties is important for the advancement of disease modeling studies with iPSCs.

AB - Recently, induced pluripotent stem cells (iPSCs) have attracted attention as a novel tool for the modeling of disease because of their potential to reveal new insights that have not been elucidated using animal models. Since iPSC generation was first reported, there have been many efforts to improve the method of generating iPSCs for clinical applications. To date, many methods for iPSC generation have been reported. Each has advantages and disadvantages for the modeling of disease, and thus the most appropriate method differs depending on the intended use of the iPSCs. Additionally, as the study of disease modeling with human iPSCs has progressed, the need to remove uncertainties due to variations in iPSCs cell lines has increasingly focused researchers’ attention on attaining experimental accuracy. Recognition of these uncertainties is important for the advancement of disease modeling studies with iPSCs.

KW - Cell reprogramming

KW - Disease modeling

KW - Induced pluripotent stem cells

UR - http://www.scopus.com/inward/record.url?scp=84978299757&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978299757&partnerID=8YFLogxK

U2 - 10.1007/978-4-431-55966-5_1

DO - 10.1007/978-4-431-55966-5_1

M3 - Chapter

SN - 9784431559641

SP - 1

EP - 9

BT - Human iPS Cells in Disease Modelling

PB - Springer Japan

ER -